Since our inception in 2004, our steadfast focus has been providing research grants to the worlds’ leading scientists researching Alzheimer’s disease. We are honored to work with scientists who are passionate in their pursuit to rid our world of this debilitating disease.

Many of the funded projects have resulted in significant breakthroughs in developing a better understanding of Alzheimer’s disease and getting closer to a cure.

Mathias Jucker, Stefan Lichtenthaler, Stephan Kaeser, | 2022

Cerebrospinal Fluid Neuroinflammatory Signature in Alzheimer´s Disease and Related Proteopathies

Evandro F. Fang, | 2022

Turning Up Mitophagy to Blunt Alzheimer’s Tau Pathologies

Alexandre Bonnin, | 2022

Prenatal Inflammation Effects on Blood-Brain Barrier Function and Alzheimer’s Disease-Related Pathologies Across the Lifespan

Jacob Hooker, | 2022

Neuroimmune Consortium: Biomarker Tool Development

Andrew Yang, | 2022

Understanding How Human Brain Vascular Cells Mediate Genetic Risk for Alzheimer’s Disease

Sam Gandy, Michelle E. Ehrlich, | 2022

Microglial-Specific INPP5D Knockdown Modulates Behavior, Amyloidosis and Tauopathy in Alzheimer’s Mouse Models

Francisco J. Quintana, | 2022

Neuroimmune Connectome Perturbations in Alzheimer’s Disease

Cheryl Wellington, | 2022

APOE Consortium: Effect of Cholesteryl Ester Transfer Protein Activity on Amyloid and Cerebrovascular Pathologies in Animal Models of Alzheimer’s Disease

David Holtzman, | 2022

APOE Consortium: Role of APOE Isoforms in Immune Responses in a Model of Tauopathy

Oleg Butovsky, | 2022

APOE Consortium: APOE4-Mediated Dysfunction of CD8 T-Cell-Microglia Crosstalk in Alzheimer’s Disease

Guojun Bu, | 2022

APOE Consortium: APOE Genotype-Specific Effects of Human Young Plasma on Cerebrovasculature and Alzheimer’s Disease Pathology

P. Murali Doraiswamy, | 2020

Sex Differences in Alzheimer’s Disease Progression: Framingham Heart Study

Funded Projects

The science that has advanced our understanding of Alzheimer's disease